Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Cardiovascular4053 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A01964 | 34550043 | Adipocyte | Sodium glucose cotransporter 2 inhibitor dapagliflozin depressed adiposity and ameliorated hepatic steatosis in high-fat diet induced obese mice. | 2021 | Details |
| A01973 | 34546515 | Obes Surg | Changes in Total Homocysteine and Glutathione Levels After Laparoscopic Sleeve Gastrectomy in Children with Metabolic-Associated Fatty Liver Disease. | 2021 | Details |
| A01975 | 34546125 | Radiology | Quantification of Liver Fat Content with CT and MRI: State of the Art. | 2021 | Details |
| A01978 | 34543735 | Diabetes Metab | Cross-talk between non-alcoholic fatty liver disease and cardiovascular disease: implications for future trial design. | 2021 | Details |
| A02002 | 34533632 | J Gastroenterol | Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020. | 2021 | Details |
| A02004 | 34533266 | Hepatol Res | Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020. | 2021 | Details |
| A02007 | 34532996 | Hepatol Commun | TM6SF2: A Novel Genetic Player in Nonalcoholic Fatty Liver and Cardiovascular Disease. | 2021 | Details |
| A02055 | 34519030 | Eur J Clin Invest | Hydrogen sulphide in liver glucose/lipid metabolism and non-alcoholic fatty liver disease. | 2021 | Details |
| A02059 | 34517014 | Metabolism | Non-alcoholic fatty liver disease, metabolic goal achievement with incident cardiovascular disease and eGFR-based chronic kidney disease in patients with prediabetes and diabetes. | 2021 | Details |
| A02080 | 34511460 | Georgian Med News | [METABOLIC FEATURES OF ADIPOSE TISSUE AND CLINICAL SIGNIFICANCE OF ADIPOKINS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (REVIEW)]. | 2021 | Details |
| A02098 | 34508601 | J Clin Endocrinol Metab | Association of MAFLD With Diabetes, Chronic Kidney Disease, and Cardiovascular Disease: A 4.6-Year Cohort Study in China. | 2022 | Details |
| A02105 | 34505899 | Nephrol Dial Transplant | Prevalence of non-alcoholic fatty liver disease in patients with chronic kidney disease: a case-control study. | 2021 | Details |
| A02121 | 34498502 | Ann Med | High NAFLD fibrosis score in non-alcoholic fatty liver disease as a predictor of carotid plaque development: a retrospective cohort study based on regular health check-up data in China. | 2021 | Details |
| A02124 | 34497708 | Ther Adv Endocrinol Metab | Therapeutic approaches for non-alcoholic steatohepatitis. | 2021 | Details |
| A02125 | 34497507 | Front Aging Neurosci | Cardiometabolic Modification of Amyloid Beta in Alzheimer's Disease Pathology. | 2021 | Details |
| A02126 | 34497431 | World J Gastroenterol | Brain-gut-liver interactions across the spectrum of insulin resistance in metabolic fatty liver disease. | 2021 | Details |
| A02140 | 34490362 | Front Cardiovasc Med | The Risk of Type 2 Diabetes and Coronary Artery Disease in Non-obese Patients With Non-alcoholic Fatty Liver Disease: A Cohort Study. | 2021 | Details |
| A02143 | 34489307 | Gut | Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort. | 2021 | Details |
| A02144 | 34488621 | Mol Med | MiR-100 overexpression attenuates high fat diet induced weight gain, liver steatosis, hypertriglyceridemia and development of metabolic syndrome in mice. | 2021 | Details |
| A02169 | 34476007 | J Cancer | Research progress, challenges and perspectives on PNPLA3 and its variants in Liver Diseases. | 2021 | Details |
| A02179 | 34472683 | Hepatol Res | MAFLD: Renovation of clinical practice and disease awareness of fatty liver. | 2021 | Details |
| A02187 | 34469404 | J Clin Gastroenterol | Management of Cardiometabolic Complications in Patients With Nonalcoholic Fatty Liver Disease: A Review of the Literature With Recommendations. | 2021 | Details |
| A02191 | 34466334 | Cureus | Effective Treatment of Nonalcoholic Fatty Liver Disease Using a Community-Based Weight Management Program. | 2021 | Details |
| A02197 | 34464720 | Clin Gastroenterol Hepatol | Serum Biomarkers are Associated With Atherosclerotic Cardiovascular Disease Among Patients With Nonalcoholic Fatty Liver Disease Undergoing Elective Angiography. | 2021 | Details |
| A02199 | 34463983 | Periodontol 2000 | Periodontal disease-related nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: An emerging concept of oral-liver axis. | 2021 | Details |
| A02211 | 34459096 | Liver Int | Changing clinical management of NAFLD in Asia. | 2021 | Details |
| A02234 | 34450194 | Prog Lipid Res | PARPs in lipid metabolism and related diseases. | 2021 | Details |
| A02238 | 34449492 | Medicine (Baltimore) | Gut-flora metabolites is not associated with synchronous carotid artery plaque and non-alcoholic fatty liver disease in asymptomatic adults: A STROBE-compliant article. | 2021 | Details |
| A02239 | 34449489 | Medicine (Baltimore) | Association between higher pericoronary adipose tissue attenuation measured by coronary computed tomography angiography and nonalcoholic fatty liver disease: A matched case-control study. | 2021 | Details |
| A02251 | 34446271 | Clin Ther | Emerging and Established Therapeutic Approaches for Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A02262 | 34444750 | Nutrients | Plasma Free Fatty Acid Concentration as a Modifiable Risk Factor for Metabolic Disease. | 2021 | Details |
| A02269 | 34441013 | Medicina (Kaunas) | Association between the Severity of Nonalcoholic Fatty Liver Disease and the Risk of Coronary Artery Calcification. | 2021 | Details |
| A02301 | 34430188 | Cureus | In-Hospital Outcomes of Patients With Non-Alcoholic Fatty Liver Disease Who Underwent Percutaneous Coronary Intervention: A Nationwide Inpatient Sample Analysis. | 2021 | Details |
| A02327 | 34417588 | Nat Rev Endocrinol | Hepatic sexual dimorphism - implications for non-alcoholic fatty liver disease. | 2021 | Details |
| A02330 | 34416040 | Aliment Pharmacol Ther | Review article: non-alcoholic fatty liver disease and cardiovascular diseases: associations and treatment considerations. | 2021 | Details |
| A02335 | 34414181 | Front Cell Dev Biol | Phytochemicals: Targeting Mitophagy to Treat Metabolic Disorders. | 2021 | Details |
| A02369 | 34400217 | Metabolism | Diabetes and metabolic dysfunction-associated fatty liver disease. | 2021 | Details |
| A02374 | 34399486 | Food Res Int | Protective and ameliorating effects of probiotics against diet-induced obesity: A review. | 2021 | Details |
| A02377 | 34397849 | Medicine (Baltimore) | Decline in serum albumin concentration is a predictor of serious events in nonalcoholic fatty liver disease. | 2021 | Details |
| A02379 | 34397640 | Eur J Gastroenterol Hepatol | The role of mean platelet volume in nonalcoholic fatty liver disease without cardiovascular comorbidities, obesity and diabetes mellitus. | 2021 | Details |
| A02381 | 34396467 | Rev Endocr Metab Disord | Applications of artificial intelligence (AI) in researches on non-alcoholic fatty liver disease(NAFLD) : A systematic review. | 2021 | Details |
| A02382 | 34396022 | J Endocr Soc | Liver Fibrosis Indices for the Prediction of Mortality in Korean Subjects: A 16-Year Prospective Cohort Study. | 2021 | Details |
| A02391 | 34391652 | J Cardiothorac Vasc Anesth | Management of Patients With Non-alcoholic Steatohepatitis Undergoing Liver Transplantation: Considerations for the Anesthesiologist. | 2021 | Details |
| A02398 | 34387409 | Diabetes Obes Metab | A clinical overview of non-alcoholic fatty liver disease: A guide to diagnosis, the clinical features, and complications-What the non-specialist needs to know. | 2021 | Details |
| A02414 | 34382495 | Ann Med | Effects of PPM1K rs1440581 and rs7678928 on serum branched-chain amino acid levels and risk of cardiovascular disease. | 2021 | Details |
| A02417 | 34381424 | Front Endocrinol (Lausanne) | Nonalcoholic Fatty Liver Disease, Liver Fibrosis and Cardiovascular Disease in the Adult US Population. | 2021 | Details |
| A02418 | 34381196 | Nat Rev Endocrinol | GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease. | 2021 | Details |
| A02420 | 34380057 | J Hepatol | Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States. | 2021 | Details |
| A02423 | 34375691 | Pharmacol Ther | Xyloketal B: A marine compound with medicinal potential. | 2021 | Details |
| A02440 | 34371198 | Prostaglandins Other Lipid Mediat | Lipocalin-type Prostaglandin D2 Synthase appears to function as a Novel Adipokine Preventing Adipose Dysfunction in response to a High Fat Diet. | 2021 | Details |
| A02443 | 34370218 | Clin J Gastroenterol | Efficacy of elafibranor in patients with liver abnormalities especially non-alcoholic steatohepatitis: a systematic review and meta-analysis. | 2021 | Details |
| A02458 | 34364973 | Biochim Biophys Acta Gen Subj | Copper and lipid metabolism: A reciprocal relationship. | 2021 | Details |
| A02464 | 34362281 | Scand J Gastroenterol | Negative interaction of fatty liver and hypertension on cardiovascular mortality in non-diabetic men: 34 years of follow-up. | 2021 | Details |
| A02474 | 34360538 | Int J Mol Sci | Diabetes Mellitus and Cardiovascular Diseases: Nutraceutical Interventions Related to Caloric Restriction. | 2021 | Details |
| A02479 | 34359438 | Foods | Comparison of Egg Yolk and Soybean Phospholipids on Hepatic Fatty Acid Profile and Liver Protection in Rats Fed a High-Fructose Diet. | 2021 | Details |
| A02482 | 34358793 | Curr Opin Pharmacol | Very-low-calorie ketogenic diet: An alternative to a pharmacological approach to improve glycometabolic and gonadal profile in men with obesity. | 2021 | Details |
| A02488 | 34356275 | Healthcare (Basel) | Prediction of Cardiovascular Risk Using Nonalcoholic Fatty Liver Disease Scoring Systems. | 2021 | Details |
| A02502 | 34349877 | Nutr Res Pract | Efficacy of nobiletin in improving hypercholesterolemia and nonalcoholic fatty liver disease in high-cholesterol diet-fed mice. | 2021 | Details |
| A02505 | 34348882 | Dig Liver Dis | Genetic predisposition, lifestyle risk, and obesity associate with the progression of nonalcoholic fatty liver disease. | 2021 | Details |
| A02518 | 34343274 | Endocrinology | SGLT2 Inhibition for Cardiovascular Diseases, Chronic Kidney Disease, and NAFLD. | 2021 | Details |
| A02519 | 34342335 | Ann Acad Med Singap | New-onset cardiovascular risk factors following liver transplantation: A cohort analysis in Singapore. | 2021 | Details |
| A02524 | 34341404 | Sci Rep | Sarcopenia modifies the associations of nonalcoholic fatty liver disease with all-cause and cardiovascular mortality among older adults. | 2021 | Details |
| A02534 | 34337887 | J Cachexia Sarcopenia Muscle | Risk stratification using sarcopenia status among subjects with metabolic dysfunction-associated fatty liver disease. | 2021 | Details |
| A02536 | 34336516 | Cureus | Perception of Non-Alcoholic Fatty Liver Disease: Real-Life Experience From Pakistan. | 2021 | Details |
| A02547 | 34332133 | Clin Res Hepatol Gastroenterol | Non-invasive diagnosis and follow-up of non-alcoholic fatty liver disease. | 2021 | Details |
| A02565 | 34327498 | Am J Prev Cardiol | Health disparities in cardiometabolic risk among Black and Hispanic youth in the United States. | 2021 | Details |
| A02566 | 34327473 | Am J Prev Cardiol | The risk of cardiometabolic disorders in lean non-alcoholic fatty liver disease: A longitudinal study. | 2020 | Details |
| A02567 | 34326946 | World J Diabetes | Exploring new treatment options for polycystic ovary syndrome: Review of a novel antidiabetic agent SGLT2 inhibitor. | 2021 | Details |
| A02579 | 34324263 | Diabetes Obes Metab | Non-alcoholic fatty liver disease-related risk of cardiovascular disease and other cardiac complications. | 2021 | Details |
| A02608 | 34311133 | Clin Res Hepatol Gastroenterol | How will NAFLD change the liver transplant landscape in the 2020s? | 2021 | Details |
| A02613 | 34309833 | Eur J Clin Invest | Is there an 'ideal' diet for patients with NAFLD? | 2021 | Details |
| A02617 | 34308754 | Tissue Barriers | Effect of Adipose derived mesenchymal stem cells on multiple Organ Injuries in diet-induced obese mice. | 2021 | Details |
| A02661 | 34294580 | Dig Liver Dis | Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease. | 2021 | Details |
| A02664 | 34293354 | J Invest Dermatol | Subclinical Liver Disease Is Associated with Subclinical Atherosclerosis in Psoriasis: Results from Two Observational Studies. | 2021 | Details |
| A02667 | 34292171 | Eur J Endocrinol | A recurrent familial partial lipodystrophy due to a monoallelic or biallelic LMNA founder variant highlights the multifaceted cardiac manifestations of metabolic laminopathies. | 2021 | Details |
| A02670 | 34290320 | Sci Rep | AST to Platelet Ratio Index (APRI) is an easy-to-use predictor score for cardiovascular risk in metabolic subjects. | 2021 | Details |
| A02674 | 34289506 | Semin Liver Dis | Novel Antidiabetic Strategies and Diabetologists' Views in Nonalcoholic Steatohepatitis. | 2021 | Details |
| A02675 | 34289397 | J Hepatol | Maternal obesity increases the risk and severity of NAFLD in offspring. | 2021 | Details |
| A02691 | 34280550 | Clin Gastroenterol Hepatol | Risk Difference of Liver-Related and Cardiovascular Events by Liver Fibrosis Status in Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A02705 | 34277667 | Front Med (Lausanne) | NAFLD or MAFLD: Which Has Closer Association With All-Cause and Cause-Specific Mortality?-Results From NHANES III. | 2021 | Details |
| A02713 | 34276185 | Ann Gastroenterol | Alcohol consumption in patients with nonalcoholic fatty liver disease: yes, or no? | 2021 | Details |
| A02731 | 34269508 | J Clin Hypertens (Greenwich) | Ectopic pancreatic fat as a risk factor for hypertension in children and adolescents with nonalcoholic fatty liver disease. | 2021 | Details |
| A02736 | 34265444 | Clin Gastroenterol Hepatol | Natural History of Nonalcoholic Fatty Liver Disease With Normal Body Mass Index: A Population-Based Study. | 2021 | Details |
| A02737 | 34265276 | Lancet Gastroenterol Hepatol | Incorporating fatty liver disease in multidisciplinary care and novel clinical trial designs for patients with metabolic diseases. | 2021 | Details |
| A02744 | 34262716 | Food Sci Nutr | Effect of garlic powder supplementation on blood pressure and hs-C-reactive protein among nonalcoholic fatty liver disease patients: A randomized, double-blind, placebo-controlled trial. | 2021 | Details |
| A02754 | 34258604 | Med (N Y) | A genome-first approach to mortality and metabolic phenotypes in MTARC1 p.Ala165Thr (rs2642438) heterozygotes and homozygotes. | 2021 | Details |
| A02780 | 34243194 | Semin Liver Dis | Risks and Rewards of Bariatric Surgery in Advanced Chronic Liver Diseases. | 2021 | Details |
| A02781 | 34243193 | Semin Liver Dis | Management of Obesity and Nonalcoholic Fatty Liver Disease: A Literature Review. | 2021 | Details |
| A02793 | 34238770 | Gut Liver | Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease. | 2022 | Details |
| A02800 | 34234682 | Front Pharmacol | The Anti-Obesity Effect of Traditional Chinese Medicine on Lipid Metabolism. | 2021 | Details |
| A02824 | 34229038 | Clin Gastroenterol Hepatol | A Global Survey of Physicians Knowledge About Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A02851 | 34219352 | Liver Int | Incidence of liver-related morbidity and mortality in a population cohort of non-alcoholic fatty liver disease. | 2021 | Details |
| A02867 | 34211743 | Curr Health Sci J | Assessment of Left Ventricular Diastolic Function in Young Adults with Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A02878 | 34208774 | Int J Mol Sci | Atorvastatin Modulates Bile Acid Homeostasis in Mice with Diet-Induced Nonalcoholic Steatohepatitis. | 2021 | Details |
| A02883 | 34206404 | Int J Mol Sci | Endothelial Progenitor Cells Dysfunctions and Cardiometabolic Disorders: From Mechanisms to Therapeutic Approaches. | 2021 | Details |
| A02886 | 34205674 | Int J Mol Sci | The Evolving Role of Fetuin-A in Nonalcoholic Fatty Liver Disease: An Overview from Liver to the Heart. | 2021 | Details |
| A02893 | 34204225 | Entropy (Basel) | Assessment of Classification Models and Relevant Features on Nonalcoholic Steatohepatitis Using Random Forest. | 2021 | Details |
| A02897 | 34203309 | Int J Mol Sci | Mitochondrial Lipid Homeostasis at the Crossroads of Liver and Heart Diseases. | 2021 | Details |
| A02936 | 34191823 | PLoS One | Significantly higher atherosclerosis risks in patients with obstructive sleep apnea and non-alcoholic fatty liver disease. | 2021 | Details |
| A02944 | 34189448 | JHEP Rep | Epidemiology of non-alcoholic fatty liver disease and hepatocellular carcinoma. | 2021 | Details |